BLFS - BioLife Solutions Inc Market Capitalization

Public company logo of biolifesolutions.com (BLFS)

BioLife Solutions, Inc. (BLFS) relies on the integration of its solutions into FDA regulations, which guarantees absolute loyalty from B2B partners. The business also develops specialized containers and media for the secure delivery of biomaterials, maintaining logistics profitability. The recruitment of rare cryopreservation experts drives technological growth, and the market capitalization stands at 1.89. This chart illustrating the price evolution of the quotes below confirms the company's market dynamics.

BLFS biolifesolutions.com: Market Capitalization in the range 07/04/2022 - 10/18/2026

BioLife - analytical breakdowns and key metrics (BLFS)

- market price and analyst price targets:
Fundamental company analysis:BioLife Solutions BLFS
Original product of BioLife

Market capitalization represents the aggregate value of all an issuer's shares, reflecting the current market consensus regarding the business's fundamental value. By analyzing the capitalization dynamics of BioLife Solutions, Inc. (BLFS), an investor identifies trend reversal points, assessing how the market re-evaluates the value of BioLife Solutions, Inc. (BLFS) ESG integration into the production of energy-efficient cryopreservation systems and eco-friendly packaging solutions for cell therapy.

Who BioLife Solutions, Inc. competes with

Market Value Tempus TEM|Qiagen NV - Market Value|Ionis Pharma - Market Capitalization|Market Valuation RGEN|Avidity Biosciences (RNA) - Market Value|CRSP - Market Capitalization|WGS (GeneDx) - Market Capitalization|Market Capitalization RARE (Ultragenyx Pharmaceutical Inc.)|Market Value Beam Therapeutics Corp (BEAM)|Sarepta Corp - Market Capitalization|Market Capitalization TWST (Twist Bioscience)|Market Capitalization 10xgenomics.com TXG|Intellia Therapeutics, Inc. - Market Capitalization|STOK: Market Value|WVE: Market Capitalization|MAZE - Market Capitalization|Market Value Sionna Therapeutics Inc|Market Value primemedicine.com PRME|Market Value Taysha Gene Therapies, Inc. (TSHA)|Market Value QURE (uniQure NV)|Market Capitalization MGTX (MeiraGTx PLC)|Market Capitalization REGENXBIO Corp (RGNX)|Solid Biosciences Inc. - Market Capitalization|Market Valuation OCGN|PACB: Market Capitalization|Market Value Benitec Biopharma Inc (BNTC)|Market Valuation DSGN|RCKT: Market Value|Market Value 4D Molecular Therapeutics (FDMT)|Market Capitalization lexeotx.com|Market Value Korro Bio KRRO|Editas Medicine Inc (EDIT) - Market Value|SLN - Market Value|PRQR: Market Value|CDXS (codexis.com) - Market Valuation|sangamo.com (SGMO) - Market Capitalization|Market Valuation NAUT|MGX (Metagenomi Inc.) - Market Value|Market Capitalization DTIL|Market Capitalization generationbio.com|Market Value Boundless Bio, Inc. BOLD|Exicure Inc. (XCUR) - Market Value|IMNN - Market Value|PHIO (Phio Pharmaceuticals) - Market Capitalization|mustangbio.com (MBIO) - Market Value|RNAZ - Market Capitalization|Market Valuation BNGO|APDN: Market Value|Market Capitalization BLUE|Market Capitalization immunoprecise.com|Market Value Omega OMGA|OMIC: Market Capitalization|Regulus Therapeutics - Market Capitalization|syros.com (SYRS) - Market Valuation|TBIO (Telesis Bio) - Market Valuation|TCON - Market Capitalization|UBX (Unity Bio) - Market Capitalization